Healthcare & Medical Devices Global On demand · 24-48h

Global Stool Sample Collection Kit Market Strategic Research Report

Global Stool Sample Collection Kit Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Stool Sample Collection Kit Market
$2432025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Sterile, Non-sterile

By Application: Gastrointestinal Infection Testing, Clinical Microbiological Culture, Molecular Diagnostics, Parasite Testing, Digestive Function Testing, Drug R&D and Clinical Trials, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, DNA Genotek Inc.(OraSure Technologies), Zymo Research Corporation, Norgen Biotek, Cell Projects(Isohelix), Canvax, DANAGEN, Tiaris Biosciences, COPAN Italia, Meridian Bioscience, SARSTEDT, Starplex Scientific, Aptaca, Kartell Labware, Puritan Medical Products, Medical Wire & Equipment Co. (MWE), Excretas Medical, MGI Tech, Xiamen Zeesan Biotech, Medico Technology, Citotest Scientific, KANGJIAN Medical, Zhejiang Gongdong Medical Technology, Huachenyang

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 157 pages
Market size 2025
$243
Million USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$355.8
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Stool Sample Collection Kit market size is predicted to grow from US$ 243 million in 2025 to US$ 360 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

In 2025, global Stool Sample Collection Kit production reached approximately 102,609 k units,with an average global market price of around US$ 2.3 per unit, and a gross profit margin of approximately 20%-40%. Stool sample collection kit is a single-use specimen-management set designed to obtain a representative fecal sample and transfer it safely to a laboratory without leakage, contamination or unacceptable analyte degradation. A typical kit may contain a collection paper or tray, spoon, spatula or swab, leak-resistant specimen container, identification label, gloves, instructions and a biohazard transport bag. Advanced products include Cary-Blair medium, parasite fixatives or molecular stabilization solutions to preserve enteric microorganisms, human or microbial DNA and RNA, proteins, metabolites, antigens or other biomarkers. Kits are configured for defined specimen quantities, storage temperatures, transport periods and downstream procedures such as culture, microscopy, immunoassay, PCR, sequencing or mass spectrometry. The product itself normally does not perform a diagnostic test; its principal functions are hygienic collection, standardized sample transfer, preservation, traceability and safe transportation. Products may be supplied for research, clinical diagnostics, epidemiological programs, veterinary testing or at-home sample return.

The upstream supply chain includes medical-grade polypropylene or polystyrene containers, screw caps, integrated spoons, collection papers, trays, flocked or foam swabs, labels, gloves and biohazard packaging. Chemical inputs include Cary-Blair transport medium, formalin, SAF and PVA parasite fixatives, buffering salts, antimicrobial agents, nucleic-acid stabilizers, pathogen-inactivation reagents and preservatives for proteins or metabolites. Midstream operations comprise injection molding, swab production, formulation development, reagent preparation and filling, cleanroom assembly, sterilization, leak testing, stability validation, packaging, regulatory registration and OEM manufacturing. Product competitiveness depends on collection convenience, sample-volume consistency, analyte stability, organism viability, odor control, transport temperature, automation compatibility and patient compliance. Downstream customers include hospitals, diagnostic and public-health laboratories, microbiome companies, pharmaceutical and biotechnology companies, contract research organizations, universities, biobanks, veterinary laboratories and home-testing providers. Distribution occurs through direct institutional sales, laboratory distributors, private-label agreements and mail-back programs. Laboratories subsequently perform culture, microscopy, antigen testing, immunoassay, PCR, sequencing, proteomics or metabolomics analysis.

This report presents a comprehensive overview of the global Stool Sample Collection Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Sterile
  • Non-sterile

Segment by Volume

  • Volume: 20 ml
  • Volume: 30 ml
  • Volume: 60 ml
  • Others

Segment by Material

  • Material: Polystyrene (PS)
  • Material: Polypropylene (PP)
  • Others

Segment by Application

  • Gastrointestinal Infection Testing
  • Clinical Microbiological Culture
  • Molecular Diagnostics
  • Parasite Testing
  • Digestive Function Testing
  • Drug R&D and Clinical Trials
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Stool Sample Collection Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Gastrointestinal Infection Testing, Clinical Microbiological Culture, Molecular Diagnostics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Stool Sample Collection Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$243
2025
Forecast
$355.8
2032
CAGR
5.6%
2025–2032
リージョン
5
global
Key companies
Thermo Fisher ScientificDNA Genotek Inc.(OraSure Technologies)Zymo Research CorporationNorgen BiotekCell Projects(Isohelix)CanvaxDANAGENTiaris Biosciences
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
SterileNon-sterile
By Application
Gastrointestinal Infection TestingClinical Microbiological CultureMolecular DiagnosticsParasite TestingDigestive Function TestingDrug R&D and Clinical TrialsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Sterile
  • 3.1.3 Non-sterile
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Gastrointestinal Infection Testing
  • 4.1.3 Clinical Microbiological Culture
  • 4.1.4 Molecular Diagnostics
  • 4.1.5 Parasite Testing
  • 4.1.6 Digestive Function Testing
  • 4.1.7 Drug R&D and Clinical Trials
  • 4.1.8 Others
  • 4.1.9 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 DNA Genotek Inc.(OraSure Technologies)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Zymo Research Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Norgen Biotek
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cell Projects(Isohelix)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Canvax
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 DANAGEN
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tiaris Biosciences
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 COPAN Italia
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Meridian Bioscience
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 SARSTEDT
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Starplex Scientific
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Aptaca
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Kartell Labware
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Puritan Medical Products
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Medical Wire & Equipment Co. (MWE)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Excretas Medical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 MGI Tech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Xiamen Zeesan Biotech
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Medico Technology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Citotest Scientific
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 KANGJIAN Medical
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Zhejiang Gongdong Medical Technology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Huachenyang
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Stool Sample Collection Kit market?
The global Stool Sample Collection Kit market is estimated at US$ 243 million in 2025 (base year) and is projected to reach US$ 360 million by 2032.
What is the forecast CAGR for the Stool Sample Collection Kit market?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 243 million in 2025 to US$ 360 million in 2032, roughly 1.5 times its base-year value.
What is Stool Sample Collection Kit?
In 2025, global Stool Sample Collection Kit production reached approximately 102,609 k units,with an average global market price of around US$ 2.3 per unit, and a gross profit margin of approximately 20%-40%. Stool sample collection kit is a single-use specimen-management set designed to obtain a representative fecal sample and transfer it safely to a laboratory without leakage, contamination or unacceptable analyte degradation.
How is the Stool Sample Collection Kit market segmented by type?
By type, the market is segmented into Sterile and Non-sterile.
What are the key applications of Stool Sample Collection Kit?
Key applications covered include Gastrointestinal Infection Testing, Clinical Microbiological Culture, Molecular Diagnostics, Parasite Testing, Digestive Function Testing, Drug R&D and Clinical Trials and Others.
Which companies are profiled in the Stool Sample Collection Kit market report?
Key players profiled include Thermo Fisher Scientific, DNA Genotek Inc.(OraSure Technologies), Zymo Research Corporation, Norgen Biotek, Cell Projects(Isohelix), Canvax, DANAGEN and Tiaris Biosciences, among 24 companies covered in total.
What geographies does the Stool Sample Collection Kit market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Stool Sample Collection Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Gastrointestinal Infection Testing, Clinical Microbiological Culture and Molecular Diagnostics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Stool Sample Collection Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.